Cardizem SR
Executive Summary
Marion development partner Elan notes capacity to produce 600 mil. doses annually. "At Marion's request we are investigating contingencies to take this to 1 bil. doses," Elan said. The b.i.d. diltiazem was recommended for approval as an antihypertensive by FDA's Cardio-Renal Drugs Advisory Committee on Nov. 3 ("The Pink Sheet" Nov. 7, p. 4)....